(Q53059213)

English

Is postablation whole-body 131 I scintigraphy still necessary in intermediate-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL?

scientific article published on 15 August 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Is postablation whole-body 131 I scintigraphy still necessary in intermediate-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL? (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

papillary thyroid cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bin Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Yu Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Lisha Jiang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Ying He

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Rui Huang

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Anren Kuang

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

publication date

15 August 2016

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

86

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

134-140

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Initial staging of differentiated thyroid carcinoma: continued utility of posttherapy 131I whole-body scintigraphy

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Update on differentiated thyroid cancer staging

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Striving toward standardization of reporting of ultrasound features of thyroid nodules and lymph nodes: a multidisciplinary consensus statement.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Annual financial impact of well-differentiated thyroid cancer care in the United States

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence

1 reference

https://api.crossref.org/works/10.1111%2FCEN.13158

21 January 2018

Identifiers

10.1111/CEN.13158

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27434740

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53059213&oldid=1509885677"